Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levonorgestrel/ethinyl estradiol in premenstrual dysphoric disorder
NCT00128934Phase 3Completed
- Sponsor
- Pfizer
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in Premenstrual Dysphoric Disorder (PMDD) and premenstrual syndrome (PMS) comparing Levonorgestrel/Ethinyl Estradiol Arm with Placebo Arm (2 arms). Primary endpoint: Mean change in average Daily Record of Severity of Problems 21-item total daily score. Started Aug 2005; status: completed.
02
Drugs
avatrombopagethinyl estradiol
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)premenstrual syndrome (PMS)
Beyond the preview
Go deeper on NCT00128934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128934.